Zehua Wang Selected Research

Zehua Wang Research Topics

Disease

109	Neoplasms (Cancer) 04/2024 - 01/2002
46	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 01/2004
32	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 01/2005
19	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2005
16	Ovarian Epithelial Carcinoma 01/2021 - 04/2003
11	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2006
10	Carcinogenesis 01/2023 - 10/2010
6	Carcinoma (Carcinomatosis) 01/2024 - 03/2010
5	Stomach Neoplasms (Stomach Cancer) 11/2023 - 11/2021
5	Lymphatic Metastasis 09/2022 - 08/2011
5	Infections 01/2020 - 12/2002
4	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 02/2012
3	Inflammation (Inflammations) 01/2023 - 01/2017
3	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 06/2008
3	Uterine Cervical Dysplasia 01/2017 - 01/2005
2	Adenocarcinoma 01/2024 - 04/2003
2	Melanoma (Melanoma, Malignant) 01/2023 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2011
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2017
2	COVID-19 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2017
2	Hemorrhage 01/2020 - 09/2011
2	Disease Progression 02/2019 - 01/2014
2	Pre-Eclampsia (Preeclampsia) 04/2017 - 02/2004
2	Ascites 11/2015 - 01/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2006
19	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2004
14	PlatinumIBA 03/2024 - 07/2005
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2013
11	Messenger RNA (mRNA)IBA 01/2024 - 02/2004
11	MicroRNAs (MicroRNA)IBA 05/2023 - 10/2010
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2005
9	Long Noncoding RNAIBA 12/2023 - 01/2018
8	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2004
7	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 10/2009
5	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 06/2009
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2006
5	EnzymesIBA 01/2022 - 10/2009
5	Enhancer of Zeste Homolog 2 ProteinIBA 06/2018 - 04/2013
4	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2022
4	olaparibIBA 03/2024 - 03/2019
4	Conditioned Culture MediaIBA 01/2024 - 11/2014
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 11/2019
4	Epidermal Growth Factor (EGF)IBA 01/2023 - 01/2020
4	AngiopoietinsIBA 12/2022 - 01/2017
4	Immunoglobulins (Immunoglobulin)IBA 12/2022 - 01/2018
4	Cadherins (E-Cadherin)IBA 10/2021 - 12/2010
4	VimentinIBA 10/2021 - 08/2011
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 03/2019
3	IntegrinsIBA 01/2024 - 01/2023
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 01/2020
3	Angiopoietin-2IBA 12/2022 - 01/2017
3	Carboplatin (JM8)FDA LinkGeneric 08/2022 - 03/2012
3	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2005
3	HeterochromatinIBA 01/2021 - 03/2019
3	CytokinesIBA 01/2020 - 12/2002
3	Voltage-Gated Sodium ChannelsIBA 02/2019 - 02/2009
2	Glutamine (L-Glutamine)FDA Link 04/2024 - 11/2016
2	N-methyladenosineIBA 01/2024 - 01/2023
2	LigandsIBA 01/2024 - 01/2022
2	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 06/2018
2	Estrogens (Estrogen)FDA Link 12/2023 - 10/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 12/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 10/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023 - 12/2022
2	Angiopoietin-1IBA 12/2022 - 01/2017
2	Therapeutic UsesIBA 02/2021 - 12/2020
2	Estrogen ReceptorsIBA 10/2020 - 09/2013
2	TOR Serine-Threonine KinasesIBA 10/2020 - 06/2008
2	Histones (Histone)IBA 01/2020 - 10/2010
2	ImmunosorbentsIBA 01/2017 - 10/2009
2	Androgen Receptors (Androgen Receptor)IBA 11/2016 - 02/2012
2	Lysine (L-Lysine)FDA Link 11/2016 - 10/2010
2	MethyltransferasesIBA 01/2016 - 10/2010
2	CateninsIBA 04/2014 - 08/2011
2	Histone MethyltransferasesIBA 03/2014 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2013 - 01/2013
2	UbiquitinIBA 09/2013 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012 - 10/2010
2	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2011 - 06/2009
2	CollagenIBA 06/2009 - 01/2006
2	Caspase 3 (Caspase-3)IBA 01/2006 - 01/2005
2	SurvivinIBA 07/2005 - 01/2005
2	cloricromen (AD 6)IBA 03/2005 - 01/2004
1	Circulating Tumor DNAIBA 03/2024
1	integrin alpha7beta1IBA 01/2024

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2024 - 04/2003
24	Therapeutics 11/2023 - 02/2012
14	Immunotherapy 03/2024 - 01/2021
12	Hysterectomy 01/2023 - 06/2010
9	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 04/2003
7	Neoadjuvant Therapy 03/2024 - 07/2012
5	Radiotherapy 08/2022 - 03/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2023 - 01/2022
2	Intraperitoneal Injections 05/2023 - 09/2015
2	Gastrectomy 01/2023 - 01/2022
2	Aftercare (After-Treatment) 03/2012 - 01/2006
1	Knee Replacement Arthroplasty (Total Knee Replacement) 02/2024